The global oxidative stress assay market is anticipated to grow significantly at a CAGR of 7.5% over the forecast period (2021-2027). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. The companies are focusing on launches of new products to sustain in the competition. For instance, in May 2020, Arbor Assays introduced TBARS/MDA as an important addition to its extensive catalog of oxidative stress products. A new assay is a powerful tool for researchers studying the basic oxidative stress mechanisms linked to a variety of debilitating diseases.
Browse the full report description Global Oxidative Stress Assay Market, By Product (Consumables and Instruments), By Test Type (Nucleic-Acid Based Assays, Lipid Acid Assays, Protein-Based Assays, Antioxidant Capacity Assays, Enzyme-Based Assays, and Reactive Oxygen Species (ROS)-Based Assays), Technology (Enzyme-linked Immunosorbent Assay (ELISA), Chromatography, Flow Cytometry, Microscopy, and High-Content Screening) Forecast Period, 2021-2027 at https://www.omrglobal.com/industry-reports/oxidative-stress-assay-market
Moreover, Thermo Fisher Scientific has a strong presence in emerging markets. It has a good online presence, and is driven by innovation that strengthened its position in the oxidative stress assays market. Further, Merck KGaA has a strong focus on R&D and has invested 14% or more of its revenue on R&D over the last three years. Merck also has a robust product portfolio, along with a strong geographic presence and brand name. These factors make Merck a dominant player in the global oxidative stress assays market. The company further strengthened its position in the oxidative stress assays market with the acquisition of Sigma-Aldrich in 2015.
The market is driven by the rising incidence of various cellular diseases. In particular, CVD and oncology are key application areas of use of devices for detecting oxidative stress markers. As per the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Over three-quarters of CVD deaths take place in low- and middle-income countries.
Market Coverage
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Oxidative Stress Assay Market – Segmentation
By Product
By Test Type
By Technology
Global Oxidative Stress Assay Market – Segmentation by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/oxidative-stress-assay-market